Literature DB >> 10513039

Chagas' heart disease.

J A Marin Neto1, M V Simões, A V Sarabanda.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10513039     DOI： 10.1590/s0066-782x1999000300001

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  14 in total

Review 1.  The emerging role of MRI in the diagnosis and management of cardiomyopathies.

Authors:  Carlos Eduardo Rochitte; Eduardo Marinho Tassi; Afonso Akio Shiozaki
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

2.  Spirometric values associated with clinical form and risk of death and stroke in chagasic patients.

Authors:  Nickson Melo De Morais; Micássio Fernandes De Andrade; Valéria Duarte De Almeida; Lara Candice Costa De Morais Leonez; Cléber Mesquita De Andrade; Christiane Medeiros Bezerra; Ellany Gurgel Cosme Do Nascimento; José Veríssimo Fernandes; Thales Allyrio Araújo De Medeiros Fernandes
Journal:  Biomed Rep       Date:  2022-09-15

Review 3.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 4.  Epidemiology and aetiology of heart failure.

Authors:  Boback Ziaeian; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

Review 5.  Clinical and echocardiographic predictors of mortality in chagasic cardiomyopathy--systematic review.

Authors:  Clodoval de Barros Pereira Júnior; Brivaldo Markman Filho
Journal:  Arq Bras Cardiol       Date:  2014-06-06       Impact factor: 2.000

6.  Reproductive Outcomes in Rhesus Macaques (Macaca mulatta) with Naturally-acquired Trypanosoma cruzi Infection.

Authors:  April L Kendricks; Stanton B Gray; Gregory K Wilkerson; Courtney M Sands; Christian R Abee; Bruce J Bernacky; Peter J Hotez; Maria Elena Bottazzi; Suzanne L Craig; Kathryn M Jones
Journal:  Comp Med       Date:  2020-03-17       Impact factor: 0.982

7.  Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial.

Authors:  Gilberto M Sperandio da Silva; Mayara C Chambela; Andrea S Sousa; Luiz Henrique C Sangenis; Sergio S Xavier; Andréa R Costa; Pedro Emmanuel A A Brasil; Alejandro M Hasslocher-Moreno; Roberto M Saraiva
Journal:  Trials       Date:  2012-12-27       Impact factor: 2.279

8.  The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.

Authors:  Bruce Y Lee; Kristina M Bacon; Diana L Connor; Alyssa M Willig; Rachel R Bailey
Journal:  PLoS Negl Trop Dis       Date:  2010-12-14

9.  Electrocardiographic findings in acutely and chronically T. cruzi-infected mice treated by a phenyl-substituted analogue of furamidine DB569.

Authors:  Elen M de Souza; Gabriel M Oliveira; Maria de Nazaré C Soeiro
Journal:  Drug Target Insights       Date:  2007-03-05

10.  Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations.

Authors:  Fabrício C Dias; Tiago da S Medina; Celso T Mendes-Junior; Roberto O Dantas; Cristina W Pissetti; Virmondes Rodrigues Junior; Renata Dellalibera-Joviliano; José A Marin-Neto; Fredy R S Gutierrez; Philippe Moreau; João S Silva; Eduardo A Donadi
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.